Similar articles

• Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.

  Wiebke EA, Custer MC, Rosenberg SA, Lotze MT. Wiebke EA, et al. J Biol Response Mod. 1990 Apr;9(2):113-26. J Biol Response Mod. 1990. PMID: 2111373
• Tumor necrosis factor: immunologic, antitumor, metabolic, and cardiovascular activities.

  Grunfeld C, Palladino MA Jr. Grunfeld C, et al. Adv Intern Med. 1990;35:45-71. Adv Intern Med. 1990. PMID: 2405602 Review. No abstract available.
• Compromised anti-tumor responses in tumor necrosis factor-alpha knockout mice.

  Baxevanis CN, Voutsas IF, Tsitsilonis OE, Tsiatas ML, Gritzapis AD, Papamichail M. Baxevanis CN, et al. Eur J Immunol. 2000 Jul;30(7):1957-66. doi: 10.1002/1521-4141(200007)30:7<1957::AID-IMMU1957>3.0.CO;2-7. Eur J Immunol. 2000. PMID: 10940885
• Suramin inhibits tumor cell cytotoxicity mediated through natural killer cells, lymphokine-activated killer cells, monocytes, and tumor necrosis factor.

  LaPushin R, Totpal K, Higuchi M, Aggarwal BB. LaPushin R, et al. J Clin Immunol. 1994 Jan;14(1):39-49. doi: 10.1007/BF01541174. J Clin Immunol. 1994. PMID: 8132736
• [Role of the neutrophils in the pathogenesis of malignant growth].

  Kashulina AP, Tereshchenko IP. Kashulina AP, et al. Eksp Onkol. 1985;7(6):3-9. Eksp Onkol. 1985. PMID: 3910404 Review. Russian.